Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Galectin Therapeutics Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 1.3699||$ 4.11|
|Low||$ 1.30||$ 1.08|
The current last sale of $1.31 is 21.30% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
We are a clinical stage biopharmaceutical company engaged in drug research and development to create new therapies for fibrotic disease and cancer. Our drug candidates are based on our method of targeting galectin proteins, which are key mediators of biologic and pathologic functions. We use naturally occurring, readily-available plant products as starting material in manufacturing processes to create proprietary complex carbohydrates with specific molecular weights and other pharmaceutical properties. These complex carbohydrate molecules are appropriately formulated into acceptable pharmaceutical formulations. Using these unique carbohydrate-based candidate compounds that largely bind and inhibit galectin proteins, particularly galectin-3, we are undertaking the focused pursuit of therapies for indications where galectins have a demonstrated role in the pathogenesis of a given disease. ... More ...
Where does GALT fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$-0.88|
|Quarterly EPS Est:||-0.12|